These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27199537)

  • 21. An Up-to-Date Overview of the Complexity of Genotype-Phenotype Relationships in Myotonic Channelopathies.
    Morales F; Pusch M
    Front Neurol; 2019; 10():1404. PubMed ID: 32010054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical and molecular genetic analysis of a family with normokalemic periodic paralysis].
    Wei CJ; Wang D; Wang S; Jiao H; Hong DJ; Pu LH; Xiong H
    Zhonghua Er Ke Za Zhi; 2013 Jan; 51(1):47-51. PubMed ID: 23527931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic variability in childhood of skeletal muscle sodium channelopathies.
    Yoshinaga H; Sakoda S; Shibata T; Akiyama T; Oka M; Yuan JH; Takashima H; Takahashi MP; Kitamura T; Murakami N; Kobayashi K
    Pediatr Neurol; 2015 May; 52(5):504-8. PubMed ID: 25724373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influences of Pregnancy on Different Genetic Subtypes of Non-Dystrophic Myotonia and Periodic Paralysis.
    Rudnik-Schöneborn S; Witsch-Baumgartner M; Zerres K
    Gynecol Obstet Invest; 2016; 81(5):472-6. PubMed ID: 27300293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Muscle channelopathies and related diseases.
    Fontaine B
    Handb Clin Neurol; 2013; 113():1433-6. PubMed ID: 23622365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human skeletal muscle sodium channelopathies.
    Vicart S; Sternberg D; Fontaine B; Meola G
    Neurol Sci; 2005 Oct; 26(4):194-202. PubMed ID: 16193245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Familial hyperkalemic periodic paralysis: a brief review of the adult human skeletal muscle sodium channel and the application of LA-PCR to the SCN4A gene analysis].
    Sakoda S; Nakagawa M; Arimura Y; Arimura K; Osame M
    Nihon Rinsho; 1997 Dec; 55(12):3253-8. PubMed ID: 9436446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skeletal Muscle Channelopathies.
    Vivekanandam V; Munot P; Hanna MG; Matthews E
    Neurol Clin; 2020 Aug; 38(3):481-491. PubMed ID: 32703462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lower-extremity magnetic resonance imaging in patients with hyperkalemic periodic paralysis carrying the SCN4A mutation T704M: 30-month follow-up of seven patients.
    Jeong HN; Yi JS; Lee YH; Lee JH; Shin HY; Choi YC; Kim SM
    Neuromuscul Disord; 2018 Oct; 28(10):837-845. PubMed ID: 30172468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What the internist should know about hereditary muscle channelopathies.
    Bissay V; Van Malderen SCH
    Acta Clin Belg; 2018 Feb; 73(1):1-6. PubMed ID: 29088983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotype and phenotype analysis of patients with sporadic periodic paralysis.
    Sung CC; Cheng CJ; Lo YF; Lin MS; Yang SS; Hsu YC; Lin SH
    Am J Med Sci; 2012 Apr; 343(4):281-5. PubMed ID: 21841462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lower limb muscle magnetic resonance imaging in Chinese patients with myotonic dystrophy type 1.
    Song J; Fu J; Ma M; Pang M; Li G; Gao L; Zhang J
    Neurol Res; 2020 Feb; 42(2):170-177. PubMed ID: 31951783
    [No Abstract]   [Full Text] [Related]  

  • 33. Mutations of SCN4A gene cause different diseases: 2 case reports and literature review.
    Liu XL; Huang XJ; Luan XH; Zhou HY; Wang T; Wang JY; Chen SD; Tang HD; Cao L
    Channels (Austin); 2015; 9(2):82-7. PubMed ID: 25839108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine.
    Desaphy JF; Altamura C; Vicart S; Fontaine B
    J Neuromuscul Dis; 2021; 8(3):357-381. PubMed ID: 33325393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myotonic discharges discriminate chloride from sodium muscle channelopathies.
    Drost G; Stunnenberg BC; Trip J; Borm G; McGill KC; Ginjaar IH; van der Kooi AW; Zwarts MJ; van Engelen BG; Faber CG; Stegeman DF; Lateva Z
    Neuromuscul Disord; 2015 Jan; 25(1):73-80. PubMed ID: 25454733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Clinical, Myopathological, and Genetic Analysis of 20 Patients With Non-dystrophic Myotonia.
    Wang Q; Zhao Z; Shen H; Bing Q; Li N; Hu J
    Front Neurol; 2022; 13():830707. PubMed ID: 35350395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The primary periodic paralyses: diagnosis, pathogenesis and treatment.
    Venance SL; Cannon SC; Fialho D; Fontaine B; Hanna MG; Ptacek LJ; Tristani-Firouzi M; Tawil R; Griggs RC;
    Brain; 2006 Jan; 129(Pt 1):8-17. PubMed ID: 16195244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In tandem analysis of CLCN1 and SCN4A greatly enhances mutation detection in families with non-dystrophic myotonia.
    Trip J; Drost G; Verbove DJ; van der Kooi AJ; Kuks JB; Notermans NC; Verschuuren JJ; de Visser M; van Engelen BG; Faber CG; Ginjaar IB
    Eur J Hum Genet; 2008 Aug; 16(8):921-9. PubMed ID: 18337730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Permanent muscle weakness in familial hypokalaemic periodic paralysis. Clinical, radiological and pathological aspects.
    Links TP; Zwarts MJ; Wilmink JT; Molenaar WM; Oosterhuis HJ
    Brain; 1990 Dec; 113 ( Pt 6)():1873-89. PubMed ID: 2276049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The electrophysiologic diagnosis for muscle ion channelopathies].
    Arimura Y; Nakamura T; Yoshimura M; Uehara A; Arimura K; Sakoda S; Takashima H
    Rinsho Shinkeigaku; 2012; 52(11):1252-5. PubMed ID: 23196580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.